Usefulness of Xeloda, capecitabine for metastatic breast cancer (MBC) In the ambulatory practice

被引：0
|
作者：
Rodger, J
Mickiewicz, E
Giacomi, N
Vigo, S
Tatangelo, M
Formiels, H
Coppola, F
Jovtis, S
Lastiri, F
机构：
[1] Angel H Roffo, Buenos Aires, DF, Argentina
[2] Breast Clin Mama, Buenos Aires, DF, Argentina
[3] Sanat Britan Rosario, Buenos Aires, DF, Argentina
[4] Hosp Aleman, Buenos Aires, DF, Argentina
[5] Hosp Churruca, Buenos Aires, DF, Argentina
来源：
EUROPEAN JOURNAL OF CANCER | 2002年 / 38卷
关键词：
D O I：
10.1016/S0959-8049(02)80201-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
115
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
  • [41] Quality of life (QoL) improvements in patients (pts) with metastatic breast cancer (MBC) receiving capecitabine (X).
    Oliveira, C
    Beato, C
    Ribeiro, R
    Cabral, S
    Tessaro, S
    Lago, S
    Abdo, E
    Moura, G
    Perdicaris, M
    Garicochea, B
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 738S - 738S
  • [42] Biweekly docetaxel (T) and capecitabine (X) as first-line treatment of metastatic breast cancer (MBC).
    Adrover, E
    Mayordomo, JI
    Llorca, C
    Burillo, MA
    Sanz, J
    Madroñal, C
    Lorenzo, A
    Palombo, H
    Janartz, J
    Pujol, E
    Machengs, I
    Yubero, A
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S202 - S202
  • [43] Capecitabine and vinorelbine in metastatic breast cancer
    Chan, Arlene
    Verrill, Mark
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (13) : 2253 - 2265
  • [44] Trastuzumab and capecitabine for metastatic breast cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1998, 40 (1039): : 106 - 108
  • [45] FINANCIAL DISTRESS IN METASTATIC BREAST CANCER (MBC).
    Rosenzweig, Margaret
    West, B. Marlene
    Berube, Roseanne
    Matthews, Jennifer
    Stokan, Melina
    ONCOLOGY NURSING FORUM, 2017, 44 (02)
  • [46] Eribulin in Recurrent/Metastatic Breast Cancer (MBC)
    Taha Sethjiwala
    Manikandan Dhanushkodi
    Venkatraman Radhakrishnan
    Jayachandran Perumal Kalaiarasi
    Nikita Mehra
    Archit Joshi
    Arun Kumar Rajan
    Gangothri Selvarajan
    Balasubramanian Ananthi
    Priya Iyer
    Geetha Senguttuvan
    Bharathi Srilatha
    Arvind Krishnamurthy
    Sridevi Velusamy
    Selvaluxmy Ganesarajah
    Trivadi S. Ganesan
    Tenali Gnana Sagar
    Indian Journal of Gynecologic Oncology, 2019, 17
  • [47] Quality of care for metastatic breast cancer (MBC)
    Luis, Ines Vaz
    Lin, Nancy U.
    Freedman, Rachel A.
    Barry, William Thomas
    Winer, Eric P.
    Hassett, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] Eribulin in Recurrent/Metastatic Breast Cancer (MBC)
    Sethjiwala, Taha
    Dhanushkodi, Manikandan
    Radhakrishnan, Venkatraman
    Kalaiarasi, Jayachandran Perumal
    Mehra, Nikita
    Joshi, Archit
    Rajan, Arun Kumar
    Selvarajan, Gangothri
    Ananthi, Balasubramanian
    Iyer, Priya
    Senguttuvan, Geetha
    Srilatha, Bharathi
    Krishnamurthy, Arvind
    Velusamy, Sridevi
    Ganesarajah, Selvaluxmy
    Ganesan, Trivadi S.
    Sagar, Tenali Gnana
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2019, 17 (03)
  • [49] Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines
    D C Talbot
    V Moiseyenko
    S Van Belle
    S M O'Reilly
    E Alba Conejo
    S Ackland
    P Eisenberg
    D Melnychuk
    T Pienkowski
    H-U Burger
    S Laws
    B Osterwalder
    British Journal of Cancer, 2002, 86 : 1367 - 1372
  • [50] Adding Xeloda (capecitabine) to docetaxel significantly improves survival and does not compromise quality of life in patients with metastatic breast cancer.
    Twelves, C
    Fumoleau, P
    Jones, SE
    Cherubini, R
    Foimtchuk, MJ
    Kroener, JF
    Martin, M
    Mennel, RG
    Tang, SC
    Van Hazel, GA
    Wigler, N
    Osoba, D
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 307 - 307
12345